Dr Amanda Hudson PhD

Dr Hudson is a mid-career researcher in The Bill Walsh Translational Cancer Research Laboratory, Kolling Institute, Royal North Shore Hospital and University of Sydney. In her current role, she works closely with a multidisciplinary team including scientists as well as oncologist’s Dr Adrian Lee, Dr Alex Yuile and Dr Helen Wheeler. These close relationships ensure that her research remains focussed on important clinical questions. Her major research focus is on improving treatments and quality of life for glioma patients by investigating how and why gliomas change over time and why treatment resistance develops.

Since being awarded her PhD in November 2010, Dr Hudson has obtained $600,000 in fellowships, $984,206 in project funding, $159,300 in equipment grants and $8,500 in competitive conference travel grants. She has a career total of 28 publications with 877 citations, including 10 first/ joint-first or senior author publications, demonstrating her ability to successfully manage projects through to completion and excellence in written communication skills. Her work has been recognised with 2 conference awards (1 oral and 1 poster) and has had 8 other oral conference presentations selected from abstracts. In addition, preliminary data from one of her projects has led to the filing of a provisional patent (application number 2018901971).